...NASDAQ:PTX), Morristown, N.J. Pozen Inc. (NASDAQ:POZN), Chapel Hill, N.C. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. CPP Investment Board...

...funds managed by private equity firms TPG Capital and Leonard Green & Partners along with CPP Investment Board...

...funds managed by private equity firms TPG Capital and Leonard Green & Partners along with CPP Investment Board...

...$125M from the sale of royalties from HCV drug Victrelis boceprevir, which Dendreon sold to CPP Investment Board (CPPIB)...

...untreated or who have failed previous interferon and ribavirin therapy. Dendreon Corp. (NASDAQ:DNDN), Seattle, Wash. CPP Investment Board (CPPIB)...

...received nine-month royalty revenues from Treximet of $12.2 million. Pozen Inc. (NASDAQ:POZN), Chapel Hill, N.C. CPP Investment Board (CPPIB)...

...Funds managed by TPG Capital and CPP Investment Board will acquire IMS Health Inc. (NYSE:RX), a provider of...

...Columbia Investment Management; Business Development Bank of Canada; Caisse de depot et placement du Quebec; CPP Investment Board...

...Columbia Investment Management; Business Development Bank of Canada; Caisse de depot et placement du Quebec; CPP Investment Board...

...technology companies in Canada. Investors include British Columbia Investment Management; Business Development Bank of Canada; CPP Investment Board...